Studies have shown that TFRC is highly expressed in a variety of tumors, including breast cancer, glioma, ovarian cancer, lung cancer, hepatocellular carcinoma, and colon cancer, and is considered a universal cancer marker (15, 21–25). This evidence concerns the gene TFRC and cancer.